Medincell Sa Stock Price To Book
| MEDCL Stock | EUR 16.30 1.28 8.52% |
Medincell SA fundamentals help investors to digest information that contributes to Medincell's financial success or failures. It also enables traders to predict the movement of Medincell Stock. The fundamental analysis module provides a way to measure Medincell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medincell stock.
Medincell |
Medincell SA Company Price To Book Analysis
Medincell's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Medincell Price To Book | 27.59 X |
Most of Medincell's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medincell SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Medincell SA has a Price To Book of 27.5888 times. This is 7.43% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The price to book for all France stocks is 190.1% lower than that of the firm.
Medincell Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medincell's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medincell could also be used in its relative valuation, which is a method of valuing Medincell by comparing valuation metrics of similar companies.Medincell is currently under evaluation in price to book category among its peers.
Medincell Fundamentals
| Return On Asset | -0.4 | |||
| Operating Margin | (3.25) % | |||
| Current Valuation | 180.29 M | |||
| Shares Outstanding | 25.22 M | |||
| Shares Owned By Insiders | 47.40 % | |||
| Shares Owned By Institutions | 18.95 % | |||
| Price To Book | 27.59 X | |||
| Price To Sales | 20.97 X | |||
| Revenue | 4.09 M | |||
| Gross Profit | 4.09 M | |||
| EBITDA | (21.45 M) | |||
| Net Income | (24.81 M) | |||
| Cash And Equivalents | 5 M | |||
| Cash Per Share | 1.24 X | |||
| Total Debt | 16.25 M | |||
| Debt To Equity | 4.61 % | |||
| Current Ratio | 4.14 X | |||
| Book Value Per Share | (1.04) X | |||
| Cash Flow From Operations | (21.36 M) | |||
| Earnings Per Share | (1.12) X | |||
| Target Price | 14.0 | |||
| Number Of Employees | 151 | |||
| Beta | 1.02 | |||
| Market Capitalization | 215.89 M | |||
| Total Asset | 44.3 M | |||
| Z Score | 7.8 | |||
| Net Asset | 44.3 M |
About Medincell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medincell SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medincell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medincell SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medincell Stock Analysis
When running Medincell's price analysis, check to measure Medincell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medincell is operating at the current time. Most of Medincell's value examination focuses on studying past and present price action to predict the probability of Medincell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medincell's price. Additionally, you may evaluate how the addition of Medincell to your portfolios can decrease your overall portfolio volatility.